Shepherd Kaplan Krochuk’s AbbVie ABBV Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,500	Closed	-$710K	–	223
2018 Q1	$710K	Buy	+7,500	New	+$824K	0.43%	68

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Shepherd Kaplan Krochuk's ABBV Position: Q2 2026 in Review

Shepherd Kaplan Krochuk increased its AbbVie (ABBV) stake by 58% in Q2 2026, buying an estimated $240K and bringing the position to 3,026 shares worth $761K. The position accounts for 0.61% of the portfolio, ranked #38.

Shepherd Kaplan Krochuk first reported a position in ABBV in Q2 2020 and has held it in 14 quarters since. The position peaked at $1.14M in Q4 2021. 4,254 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Shepherd Kaplan Krochuk held 3,026 shares of AbbVie worth $761K as of Q2 2026.
Shepherd Kaplan Krochuk bought 1,116 AbbVie shares in Q2 2026, an estimated $240K.
AbbVie made up 0.61% of Shepherd Kaplan Krochuk's portfolio in Q2 2026, its #38 holding.
Shepherd Kaplan Krochuk first reported a position in AbbVie in Q2 2020 and has held it in 14 quarters since.
Shepherd Kaplan Krochuk's AbbVie position peaked at $1.14M in Q4 2021.
4,254 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2026, filed 14 Aug 2026.